Supernus Pharma (SUPN) Tops Q3 EPS by 44c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. META
6. MU
7. BLZE
8. PRIM
9. ACN
10. NVDA

Go back to Supernus Pharma (SUPN) Tops Q3 EPS by 44c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 44.48 --0 (-0%)
Previous Close $44.48    52 Week High $26.84 
Open $44.69    52 Week Low $9.51 
Day High $45.50    P/E N/A 
Day Low $44.44    EPS $-2.62 
Volume 526,310